Cargando…

Artificial Intelligence in Paediatric Tuberculosis

Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Jaishree, Shelmerdine, Susan Cheng, -Charcape, Carlos F. Ugas, Sodhi, Arhanjit Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883137/
https://www.ncbi.nlm.nih.gov/pubmed/36707428
http://dx.doi.org/10.1007/s00247-023-05606-9
_version_ 1784879441975967744
author Naidoo, Jaishree
Shelmerdine, Susan Cheng
-Charcape, Carlos F. Ugas
Sodhi, Arhanjit Singh
author_facet Naidoo, Jaishree
Shelmerdine, Susan Cheng
-Charcape, Carlos F. Ugas
Sodhi, Arhanjit Singh
author_sort Naidoo, Jaishree
collection PubMed
description Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strategy” and framework set out by the World Health Organization (WHO). Since the inception of artificial intelligence (AI) more than 60 years ago, the interest in AI has risen and more recently we have seen the emergence of multiple real-world applications, many of which relate to medical imaging. Nonetheless, real-world AI applications and clinical studies are limited in the niche area of paediatric imaging. This review article will focus on how AI, or more specifically deep learning, can be applied to TB diagnosis and management in children. We describe how deep learning can be utilised in chest imaging to provide computer-assisted diagnosis to augment workflow and screening efforts. We also review examples of recent AI applications for TB screening in resource constrained environments and we explore some of the challenges and the future directions of AI in paediatric TB.
format Online
Article
Text
id pubmed-9883137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98831372023-01-30 Artificial Intelligence in Paediatric Tuberculosis Naidoo, Jaishree Shelmerdine, Susan Cheng -Charcape, Carlos F. Ugas Sodhi, Arhanjit Singh Pediatr Radiol Tuberculosis Minisymposium Tuberculosis (TB) continues to be a leading cause of death in children despite global efforts focused on early diagnosis and interventions to limit the spread of the disease. This challenge has been made more complex in the context of the coronavirus pandemic, which has disrupted the “End TB Strategy” and framework set out by the World Health Organization (WHO). Since the inception of artificial intelligence (AI) more than 60 years ago, the interest in AI has risen and more recently we have seen the emergence of multiple real-world applications, many of which relate to medical imaging. Nonetheless, real-world AI applications and clinical studies are limited in the niche area of paediatric imaging. This review article will focus on how AI, or more specifically deep learning, can be applied to TB diagnosis and management in children. We describe how deep learning can be utilised in chest imaging to provide computer-assisted diagnosis to augment workflow and screening efforts. We also review examples of recent AI applications for TB screening in resource constrained environments and we explore some of the challenges and the future directions of AI in paediatric TB. Springer Berlin Heidelberg 2023-01-28 /pmc/articles/PMC9883137/ /pubmed/36707428 http://dx.doi.org/10.1007/s00247-023-05606-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Tuberculosis Minisymposium
Naidoo, Jaishree
Shelmerdine, Susan Cheng
-Charcape, Carlos F. Ugas
Sodhi, Arhanjit Singh
Artificial Intelligence in Paediatric Tuberculosis
title Artificial Intelligence in Paediatric Tuberculosis
title_full Artificial Intelligence in Paediatric Tuberculosis
title_fullStr Artificial Intelligence in Paediatric Tuberculosis
title_full_unstemmed Artificial Intelligence in Paediatric Tuberculosis
title_short Artificial Intelligence in Paediatric Tuberculosis
title_sort artificial intelligence in paediatric tuberculosis
topic Tuberculosis Minisymposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883137/
https://www.ncbi.nlm.nih.gov/pubmed/36707428
http://dx.doi.org/10.1007/s00247-023-05606-9
work_keys_str_mv AT naidoojaishree artificialintelligenceinpaediatrictuberculosis
AT shelmerdinesusancheng artificialintelligenceinpaediatrictuberculosis
AT charcapecarlosfugas artificialintelligenceinpaediatrictuberculosis
AT sodhiarhanjitsingh artificialintelligenceinpaediatrictuberculosis